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Abstract 
Gabrielle Chin 
MINDFULNESS AND BLOOD PRESSURE ACROSS DEMOGRAPHICS: 
ANALYSES FROM THE SERENITY STUDY 
2018-2019 
Jeffrey Greeson, Ph.D. 
Master of Arts in Clinical Psychology 
 
Mindfulness, as a state, trait, and training, is linked with myriad positive mental and 
physical health outcomes. Understanding the individual characteristics potentially 
influencing links between mindful traits, mindfulness training, and physical health, is 
therefore important, yet remains under-addressed. Utilizing data from the ongoing 
Serenity Study (NCT02371317), the current project examines if (1) at baseline, higher 
trait mindfulness relates to lower BP consistently as a function of demographics, (2) 
Mindfulness-Based Stress Reduction (MBSR) training lowers BP consistently across 
demographic subgroups and initial levels of trait mindfulness, and (3) if change in trait 
mindfulness following MBSR training correlates with change in BP following 
mindfulness training, consistently across demographic groups. Results show that some 
trait mindfulness facets relate differently to BP across race and gender, that MBSR 
training may not be effective at lowering BP in demographics outside of people who are 
White, that improvement in trait mindfulness may not drive change in BP after MBSR 
training, and that mindfulness research would benefit from improved sample diversity to 
explore potential demographic differences in the relationship between mindfulness and 
health, rather than assuming beneficial effects generalize across populations. 
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Chapter One 
 
Introduction 
An estimated 85.7 million adults, roughly 34% of Americans, are currently 
diagnosed as having high blood pressure (BP), or hypertension (HTN): systolic blood 
pressure (SBP) over 140 mmHg and/or diastolic blood pressure (DBP) over 90 mmHg 
(Benjamin et al, 2017). HTN is the preeminent risk factor for cardiovascular disease 
(CVD), causing 54% of stroke and 47% of ischemic heart disease events worldwide 
(Lawes, Hoorn & Rodgers, 2008). In 2010, HTN was a component in 18% of all deaths 
(9.4 million globally). The United States alone spends an estimated 46 billion dollars a 
year treating this ubiquitous condition (Campbell et al, 2015). Typically, HTN treatment 
includes antihypertensive medications, namely thiazide diuretics, beta blockers, 
Angiotensin converting enzyme inhibitors (ACE inhibitors), Angiotensin II receptor 
blockers (ARBs), and calcium channel blockers (CCBs; Chobanian, 2003), but most 
commonly a combination of thiazide diuretics and ACE inhibitors (Jarari et al., 2015). 
Both prevalence and severity of HTN differ across race. 
Black people experience the highest rates of CVD incidence and CVD morbidity 
compared with White and Hispanic people (Graham, 2015). An estimated 43.5% of non-
Hispanic Blacks, 33.0% of Hispanics, and 27.5% of non-Hispanic Whites fall within 
adult diagnosable criteria for HTN established by the 7th Report of the JNC on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure (Fei et al., 
2017). Other demographics have similar disparities-- older age is a primary risk factor for 
HTN and CVD (North & Sinclair, 2012), men have higher lifetime CVD risk and 
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morbidity than women (Mosca, Barrett-Connor & Wegner, 2011), and people with lower 
SES have higher HTN and CVD incidence and morbidity compared against higher SES 
people (Schultz et al., 2018). 
In addition, effects of antihypertensive medications vary widely across 
demographics, particularly race and degree of HTN. A single antihypertensive 
medication is unlikely to effectively control BP for more than 25-50% of patients. For 
example, ACE inhibitors are relatively ineffective at lowering BP in Black people (30% 
response rate) but are more successful in White people (55% response rate; Sever, 1998). 
Similarly, people with stage-one hypertension report better outcomes when prescribed 
CCBs, ACE inhibitors or ARBs versus thiazide diuretics or beta-blockers (Gupta, 2010). 
Most patients seen for HTN are diagnosed with elevated BP (SBP of 120-129 mmHg and 
DBP of <80 mmHg) or stage one HTN (SBP of 130-139 mmHg or DBP of 80-89 mmHg; 
Egan & Stevens-Farby, 2015).  
Alarmingly, many people with milder forms of HTN are overtreated, and given 
the same level of medication or the same medications as people with more severe BP 
levels (Kerr et al., 2012). A recent review by the Cochrane Foundation highlighted this 
discrepancy, analyzing drug treatment outcomes from 8,912 participants with pre-HTN. 
Treatment with antihypertensive medications versus placebo did not reduce total 
mortality, even after 4-5 years of medication. Furthermore, antihypertensive medications 
did not reduce rates of coronary heart disease, stroke or total cardiovascular events in 
79% of participants compared with a placebo. Adverse side-effects from 
antihypertensives caused 9% of participants to cease treatment totally (Diao, Wright, 
Cundiff & Gueyffier, 2012). Other studies have found specific and substantial adverse 
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effects of antihypertensive overmedication, including angioedema, kidney failure, 
hastened cognitive decline, and atrophy in the thalamus, putamen and hippocampus as 
well as decreased gray matter integrity (Gibbs, Lip & Beevers, 1999; Mossello et al., 
2015; Foster-Dingley et al., 2015; Foster-Dingley et al., 2015a). Although HTN is 
controllable via lifestyle modifications paired with antihypertensive medication if 
behavioral changes are ineffective (Egan & Farby, 2015), ultimately only one in five 
people with HTN successfully manages their condition with conventional treatments, 
often due to difficulty adhering to long-term lifestyle modifications and medication 
regimens (Hamer, 2010). Given the prevalence, disparities, and suboptimal outcomes for 
treating HTN, alternative approaches to managing high BP are necessary, specifically for 
people with elevated BP but not full HTN.  
Stress is another modifiable risk factor that is both an HTN source and an 
instigator of other HTN risk factors, like poor diet and physical inactivity. Although 
stress is largely environmentally driven, the perception of stress is a changeable internal 
experience, thereby stress reduction may be a favorable treatment target. Stress impacts 
BP via numerous biobehavioral mechanisms. Harmful chronic stress and cognitive 
perseveration about stressors trigger biological stress reactions in the autonomic nervous 
system and adrenocortical systems, cyclically inducing stress-related symptoms and 
illnesses. Activation of these systems causes adrenal hormones like dopamine, 
epinephrine and norepinephrine (catecholamines increasing cardiac output) to be 
released, actuating acute stress responses maintaining short term homeostasis. 
Paradoxically, effects of these stress-reactivity systems on the body are adverse when 
activated too often, too strongly, or for extended lengths of time. Observed effects 
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include damaging the immune and sympathetic nervous systems, the hippocampal-
pituitary-adrenal axis, the vascular system, and hastening global pathology (McEwen, 
2000). Allostatic load is this cumulative ‘wear and tear’ on bodily systems over time. 
Normal, adaptive allostatic processes fail, and typical cardiovascular, neuroendocrine and 
neuroenergetic responses become continuously active, leading to an inadaptability of 
associated physiological systems. For example, inadaptability of the vascular system 
increases arterial blood flow and repeatedly elevates BP, spurring development of 
preclinical vascular pathology including endothelial cell damage and general vascular 
overload, ultimately resulting in harmful vascular remodeling, in which arteries become 
narrowed and hardened with plaque, lose elasticity, and this becomes vulnerable to HNT 
(Peters, McEwen & Friston, 2017). The potency of chronic stress as a dually predictive 
and developmental factor for many diseases, particularly HTN and CVD, conveys the 
necessity of non-pharmaceutical, effective and accessible stress-reducing interventions 
that positively impact physical health, while lessening disease risks and states. (Denollet, 
Schiffer & Spek, 2010). Teaching people with high BP to better manage stress could help 
control BP in at least two ways: (1) Directly buffering cardiovascular stress reactivity 
thereby reducing allostatic load, and indirectly by (2) initiating and maintaining healthy 
lifestyle changes typically compromised by chronic stress, like diet, exercise, and sleep. 
An increasingly acknowledged potential intervention addressing this need is mindfulness. 
 Mindfulness 
Mindfulness is commonly defined as nonjudgmental awareness of one’s present-
moment experience (Kabat-Zinn, 2009). Appearing in secular healthcare settings in the 
United States 40 years ago, mindfulness practice is heralded as an innovative, non-
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pharmacologic, and cost-effective method of stress reduction. One recent national survey 
shows that 12% of Americans report using mindfulness techniques, like meditation, to 
reduce stress (Herman et al., 2017; Kabat-Zinn, 1979; American Psychological 
Association, 2017). The surging popularity of mindfulness is unsurprising, given the 
considerable evidence of its effectiveness in reducing stress and bolstering well-being 
(Greeson & Chin, 2019), and rising reports of stress and stress-related diseases across the 
world (Regus, 2014).  
Like stress, mindfulness can be conceptualized as a multidimensional concept. On 
one hand, mindfulness is an inherent trait; everyone has some natural ability to be 
mindful, and this ability varies across individuals. This is termed dispositional or trait 
mindfulness. In addition, mindfulness can be a momentary state of balanced awareness 
and acceptance, such as during meditation. Finally, mindfulness is also a training to 
develop mindfulness skills through meditation practice such as through the eight-week 
mindfulness based stress reduction (MBSR) training program (Shapiro & Carlson, 2009; 
Lindsay, Young Smyth, Brown & Creswell, 2017). In theory, several different 
mindfulness skills – sometimes called facets – are believed to reduce perceptions of stress 
and self-regulate physiological responses that, over time, contribute to risk of HTN and 
CVD (Greeson, 2009; Holzel et al., 2011; Shapiro, Carlson et al. 2005). For example, an 
observant and present-moment oriented mindset may allow accurate appraisal of a 
stressor, its context, and of subsequent cognitive, emotional, and bodily reactions. 
Theoretically, this increased self-awareness, alongside decreased judgment and increased 
acceptance of reactions to the stressor and related internal events, may reduce 
physiological reactivity during stress. Cyclically, cultivation of this ‘mindful’ reappraisal 
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system in acute stress events (including adaptive changes in cognitions, emotions, and 
physiological responses) could lead to long-term improvements in cognitions and 
behaviors related to stress (Garland, 2017). A more mindful reappraisal system, formed 
from high inherent levels of mindfulness as a trait or via mindfulness training, utilizing 
core qualities of mindfulness like Observing (noticing details of internal and external 
contexts), Describing (ability to put words to experiences), Nonjudging (accepting and 
not evaluating experienced cognitions, emotions, and sensations), Nonreactivity 
(allowing thoughts, feelings and sensations to pass without fixating or reacting to them), 
and Acting with Awareness (ability to pay attention to current activities; not being on 
‘autopilot’) could buffer acute biological stress reactivity, reduce allostatic load, and 
thereby promote healthy BP in people at-risk for or with high BP (Creswell & Lindsay, 
2014). 
Preliminary explorations of the link between trait mindfulness and physical health 
present mixed findings. A longitudinal study by Murphy, Mermelstein, Edwards and 
Cidycz (2012) found that high trait mindfulness predicted good self-reported physical 
health as measured by the Cohen-Hoberman Inventory of Physical Symptoms across a 
10-week period. A cross-sectional epidemiologic study by Loucks et al. (2015) found that 
participants with low levels of self-reported trait mindfulness as measured by the Mindful 
Attention Awareness Scale who were not obese as children were more likely to become 
obese in adulthood than participants with higher trait mindfulness scores. A later study by 
Loucks et al. (2016) demonstrated that some elements of good vascular health, like low 
fasting glucose, high physical activity, and not smoking, associated with high trait 
mindfulness, while other elements such as BP, cholesterol level, and fruit or vegetable 
  
 
 
7 
 
consumption, were not. Tomfohr, Pung, Mills and Edwards (2015) investigated the 
relationships between multiple subscales of trait mindfulness, BP, and interleukin-6 (IL-
6), resulting in varied findings, whereas higher scores on the Observing subscale of the 
FFMQ correlated with lower levels of IL-6 when scores on the Nonreactivity subscale 
were also high, with no other subscales showing associations. BP was not associated with 
any subscales except among participants with high Nonjudging scores, such that as 
Acting with Awareness increased, BP decreased. These initial results are inconclusive, 
but indicate that different facets of trait mindfulness may relate differently to biological 
markers of stress, including BP. Theoretically, improvements in trait mindfulness can 
lead to increased mindful states and behaviors, thereby impacting health, so greater 
understanding of how specific trait mindfulness facets change following mindfulness 
training may inform possible causal mechanisms by which the training improves health 
related outcomes (Carmody, Baer, Lykins & Olendzki, 2009). It is unknown if high 
levels of trait mindfulness prior to mindfulness training improve health related outcomes 
following mindfulness training, or conversely, if low levels of trait mindfulness allow for 
more ‘room to grow’ during mindfulness training, thereby increasing benefit. Given the 
relative paucity and inconsistency of data linking trait mindfulness and objective 
biomarkers on cardiovascular health, further investigation of the links between trait 
mindfulness, mindfulness training, and health in a diverse sample of adults with elevated 
BP could inform more efficient utilization of mindfulness training as a complementary 
intervention for stress-related physical conditions and diseases, like HTN and CVD. 
While it is still unclear if trait mindfulness affects or relates to BP, early studies 
indicate that mindfulness-based interventions (MBIs) may be a viable treatment for 
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stress-related physical conditions and diseases, given substantial evidence that MBIs 
decrease subjective stress both short- and long-term (Martin-Asuero, 2010; Evans et al, 
2011; Geary & Rosenthal, 2011; Britton, Shahar, Szepsenwol & Jacobs, 2012; Bergen-
Cico, Possemato & Cheon, 2013). One small randomized controlled trial (RCT) 
compared MBSR training to progressive muscle relaxation (PMR) training in 
unmedicated adults with pre-HTN and found that MBSR training significantly reduced 
both clinic SBP (4.9 mmHg) and DBP (1.9 mmHg) versus PMR (Hughes et al., 2013). 
Although changes in daytime and nighttime ambulatory SBP (3.5 mmHg) and DBP (1.4 
mmHg) did not significantly differ from PMR, ambulatory SBP change in the MBSR 
training group was clinically noteworthy (Hughes et al., 2013). BP changes of the size 
found in this trial are known to reduce incidence of heart attack, stroke, and CVD-related 
death, if sustained (Whelton et al., 2002). In contrast, a larger RCT with participants 
diagnosed with stage 1 hypertension found that MBSR training had no effect on 
ambulatory SBP (0.4 mmHg) and DBP (0.0 mmHg) compared against a waitlist control 
group (Blom et al., 2014). 
Studies of MBIs and BP reactivity to laboratory stressors generally support MBIs 
as decreasing BP reactivity, but results are not wholly consistent. One RCT found that 
MBSR training generated small decreases in BP reactivity to a mental arithmetic and 
speech task (Nyklíček et al., 2013). A 3-armed RCT comparing app-based interventions 
found that compared with other interventions, mindfulness intervention app reduced SBP 
reactivity to the Trier Social Stress Test (Lindsay et al., 2018), while another RCT found 
that brief mindfulness exercises lowered BP reactivity over the duration of a speeded 
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math stressor (Steffen & Larson, 2015). Conversely, one RCT testing a brief mindfulness 
exercise found no significant effects on BP reactivity to stress (Grant et al., 2013). 
Initial research exists investigating the links between mindfulness, stress, and 
cardiovascular health, is limited, and results are mixed. Yet, when considering 
mindfulness as either a trait or interventional approach buffering and reducing high BP, 
several critical issues in the current literature likely contribute to the apparent variation in 
findings. The bulk of people utilizing MBIs are healthy, middle-age, high-income, 
college-educated, female & White (Burke, Lam, Stussman & Yang, 2017). This specific 
population also demographically mirrors most participants studied in mindfulness 
research (Chin, Anyanso & Greeson, 2019). In contrast, the people most likely to be 
diagnosed with HTN are older-age, lower SES, male, and non-White. Minimal research 
has examined if mindfulness, as a trait or a training, influences physical health differently 
across demographic characteristics like race, age, gender, and SES. This imbalance is 
especially concerning when considering the substantial disparity of HTN alongside the 
disparity in consequent negative CVD outcomes, across demographics (Fei et al. 2017; 
Lackland, 2015). Initial research indicates that the effect of MBIs on BP is potentially 
moderated by race. Palta et al.’s small pilot study evaluating MBSR training effectiveness 
with older-adult Black participants (n = 12) produced highly significant results- more 
than quadruple the reduction in SBP (21.92 mmHg) and over eight times the reduction in 
DBP (16.7 mmHg) found in Hughes et al.’s largely White sample (Palta et al., 2012). 
Greater understanding of potential variation in how mindfulness as a trait and training 
affects people with demographically disparate, stress-related health conditions and 
diseases like HTN is increasingly important given the rising popularity of MBIs as a 
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component of stress-related disease treatment. Still, diversity in mindfulness research 
remains under-addressed. 
Furthermore, much of the existing research on the relationship between 
mindfulness and physical health utilizes subjective health measures versus objective 
health measures. Mindfulness training impacts people’s interpretations of and reactions to 
physical illness and pain, generating improvement on subjective health measures. 
Although these changes may reflect improved well-being and quality of life, subjective 
health improvement does not parallel recovery or improvement in objective health 
measures related to physical disease, like BP (Greeson & Chin, 2019). Additionally, 
studies utilizing objective measures only sporadically collect data on relevant covariates. 
Extensive past research has identified covariates of BP, yet few mindfulness trials have 
controlled for these factors when analyzing BP, even if data on these covariates are 
collected as part of the trial. Common alternatives include controlling for pre-training BP 
levels (Hughes et al., 2013; Lindsay et al., 2018), or only collecting and utilizing 
information on some of the known relevant covariates, often age, sex, BMI or 
antihypertensive use (Nyklíček et al., 2013; Palta et al., 2013). Methodological 
improvements, like increased use of objective health measures alongside controlling for 
all possible relevant covariates, may clarify how mindfulness relates to physical health. 
Therefore, the current study used both cross-sectional and longitudinal data from 
an ongoing multisite clinical trial to address methodological limitations common in the 
current field of mindfulness and cardiovascular health. Based on a review of the 
literature, and informed by pertinent theories, we propose three research questions: (1) At 
baseline, does higher trait mindfulness relate to lower BP after controlling for known 
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covariates of BP, and does this relationship differ as a function of demographics? (2) 
Does MBSR training lower BP, and does it do so across demographic subgroups and 
initial levels of trait mindfulness? (3) Finally, is change in trait mindfulness correlated 
with change in BP following MBSR training, and does this association occur across 
demographic subgroups? 
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Chapter Two 
 
Methods 
 
The current study proposed to analyze both baseline and pre-post intervention 
data from the Serenity Study (NCT02371317), an ongoing multi-site RCT comparing the 
efficacy of MBSR training and stress-management education (SME) in lowering BP 
among adults with pre-HTN.  
Participants 
 
Table 1 
Sample Demographics 
  All RCT OL 
N 296 156 140 
Race (% Black) 25% 28.1% 20.6% 
Race (% White) 69% 69.4% 68.8% 
Age 50.7 49.7 51.7 
Gender (% Female) 58% 52% 65.2% 
SES (% Lower) 47.7% 52.5% 41.9% 
BMI 28.7 29.3 28 
Smoking History (% Smoked) 22.4% 22.2% 22.7% 
Risky Drinking (% Engage) 1.4% 2.5% 0% 
Healthy Diet (% Healthy) 40.1% 37.7% 43% 
Hours Exercised/Day 2.5 2.6 2.4 
Hours Slept/Day 6.9 6.9 6.8 
Clinic SBP (mmHg) 123.7 124.4 122.8 
Clinic DP (mmHg) 72.9 73.5 72.1 
Ambulatory SBP (mmHg)   142.9   
Ambulatory DBP (mmHg)   84.5   
SBP Reactivity (mmHg)   10.9   
DBP Reactivity (mmHg)   9.1   
Observing 26.49 26.64 26.28 
Describing 28.03 28.10 27.95 
Acting with Awareness 26.71 27.09 26.31 
Nonjudging 28.08 28.13 27.97 
Nonreactivity 21.04 21.03 20.98 
Decentering 42.02 42.23 41.73 
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Baseline. Participants (N = 296; Mage = 50.69, SD = 12.77) include medicated and 
unmedicated men (42.1%) and women (57.9%) with and without pre-HTN (SBP of 120-
-139 or DBP of 80--89, consistent across two clinic assessments) as measured by criteria 
established by the 7th Report of the Joint National Committee (JNC) on Prevention, 
Detection, Evaluation and Treatment of High Blood Pressure. Regarding race, 206 
(69.1%) identified as White, 74 (24.8%) as Black, 19 (6.4%) as Asian, 6 as Native 
American/Alaskan (2%), and 1 as Pacific Islander (.3%). People were excluded from the 
RCT if they were morbidly obese (BMI = 40), if they had existing heart disease as 
evidenced by a pacemaker, atrial fibrillation, myocardial infarction, percutaneous 
transluminal coronary angioplasty, coronary artery bypass graft within six months of 
enrollment, persistent tachyarrhythmia, congestive heart failure, uncorrected primary 
valvular disease, hypertrophic or restrictive cardiomyopathy, or uncorrected thyroid 
disease, chronic kidney disease, or if they fell within JNC risk category C (including 
target organ damage and diabetes). In addition, people were excluded if they were 
pregnant or planning to become pregnant within nine months, lactating, unable to comply 
with assessment procedures, unable to provide informed consent, or had dementia; and if 
they had abused alcohol or drugs in previous 12 months, regularly consumed more than 
21 alcoholic drinks per week, been current smokers, or if they already had 27 hours of 
formal, or 56 hours of informal, meditation or yoga training. Baseline data included RCT 
participants as well as open-label participants. Open-label (OL) participants were 
excluded from the formal RCT due to not meeting eligibility criteria, but they still opted 
to take part in the MBSR training or SME interventions in exchange for providing BP 
and other relevant data. Open-label participants were mainly included to form viable 
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MBSR training and SME group sizes. Moreover, the larger combined sample size 
improved statistical power for baseline analyses. And, many of the open-label 
participants still had relatively high BP and qualified as prehypertensive, given the 
recently lowered criteria in American Heart Association high BP guidelines (Whelton et 
al., 2017). See Table 1 for further participant demographic information. 
Pre-post intervention. RCT participants in the MBSR training group (N = 44; 
Mage = 49, SD = 13.1) included unmedicated men (48.9%) and women (51.1%) with 
elevated BP, consistent across two clinic assessments) as measured by criteria established 
by the 7th Report of the JNC on Prevention, Detection, Evaluation and Treatment of High 
Blood Pressure. Among these participants, 31 (68.9%) identified as White, 11 (24.4%) as 
Black, 2 (4.4%) as Asian/Pacific Islander, and 1 as mixed-race (2.2%). People were 
excluded identically to baseline exclusion criteria. See Table 1 for further participant 
demographic information. 
Procedure 
The institutional review boards of Kent State University and University of 
Pennsylvania reviewed and approved study procedures. All potential participants 
completed initial eligibility and medical screening over the phone by study staff, or 
online via REDCap. Potential participants not excluded after the initial screening were 
then scheduled for the first in-clinic screening session, where clinic BP was determined, 
following standard American Heart Association (AHA) procedures (Pickering et al., 
2005). Potential participants were asked to refrain from vigorous exercise and consuming 
alcohol and caffeine for at least four hours before their appointment time. 
  
 
 
15 
 
Potential participants with three consistent (within 5 mmHg) pre-hypertensive BP 
readings during the initial BP screening visit were further considered as eligible. One 
week later, a second, confirmatory clinic screening of BP determined final eligibility by 
repeating the BP assessment. Participants were then consented and enrolled, and 
additional baseline assessments of demographic information and self-report measures, 
including stress and mindfulness, were completed.  
         As illustrated in Figure 1, enrolled RCT participants were randomly assigned to 
one of three conditions: (1) MBSR training, (2) a Stress Management Education (SME) 
active control group, or (3) a wait-list control (AHA Recommended Self-care). Five total 
study visits occurred following enrollment: (1) pre- class visit, (2) mid -point visit, (3) 
post- class visit, (4) at 6-month follow up, and (5) 12-month follow up. Participants 
randomized to the wait-list (AHA self-care) group also completed pre-, mid- and post- 
visits over the 8-week intervention period. Clinic BP was measured, and questionnaires 
were completed at all study visits. Participants randomized to the MBSR training or SME 
groups completed mental stress testing and ambulatory BP monitoring at the pre-class, 
post-class, and 12-month follow up visits. Participants randomized to the AHA- 
Recommended Self-care group completed mental stress testing and ambulatory BP 
monitoring at pre-self-care, post-self-care phase, and at the 12--month follow up visit 
after taking part in their stress management program of choice. Clinic BP, ambulatory BP 
procedures and mental stress testing/BP reactivity are described in the measures section 
below. OL participants (who were not enrolled in the RCT) did not take part in 
ambulatory BP or mental stress testing lab visits.  
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Figure 1. Enrolled participants were randomly assigned to one of three conditions, 
including MBSR training, an SME active control group, or AHA Recommended Self-
care, a wait-list control. 
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Measures 
Clinic BP. Clinic BP, the ‘gold standard’ measure of BP and the primary trial 
endpoint, was measured via an automatic oscillometric monitor, the Datascope Accutorr 
Plus™ (Mawah, NJ, USA). All clinic BP assessments were completed in a quiet and 
climate-controlled room, following AHA guidelines (Pickering, 2005). Participants had 
their BP reading taken from their non-dominant arm (supported at heart level) while 
seated in a chair with feet flat on the floor. The mean of three consistent seated readings 
of BP on the non-dominant arm was calculated to find clinic BP. If these three readings 
varied by more than 5 mmHg for SBP or DBP, further readings were taken at five-minute 
intervals, until either three consecutive readings ranging within 5 mmHg were collected, 
or until a maximum of six measures were taken. Potential participants whose SBP or 
DBP varied by more than 5 mmHg after six readings were considered ineligible due to 
excessive variability in BP.  
Ambulatory BP. Ambulatory BP was measured via an automatic oscillometric 
monitor, the Oscar 2™ (SunTech Medical, Morrisville, NC). Participants were asked to 
wear the monitor for 24 hours following their pre-class visit, and to keep the monitor on 
while sleeping. The monitor collected BP readings every 20 minutes during the day (6 
AM to 11 PM; 51 measures) then every 30 minutes during the night (11 PM to 6 AM; 14 
measures). During each reading, participants were instructed to drop their arms to their 
sides as soon as they sense the cuff inflating, and to keep it relaxed and still until a few 
seconds after the deflation has finished.  
BP reactivity. BP reactivity to stress was measured via an automatic 
oscillometric monitor, the Datascope Accutorr Plus™ (Mawah, NJ, USA). BP reactivity 
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was calculated as a change score, by subtracting mean BP scores during the baseline rest 
period from mean BP scores during the anger recall task (ART), a brief (5-min) 
emotional stressor in which subjects were instructed to first recall, visualize and then 
verbally describe “a time that made you angry and when you think about it today, still 
makes you angry.” (Greeson et al., 2009). The ART has been shown to reliably increase 
BP and HR (Schwartz et al., 2000). 
Demographics and self-report questionnaires. Assessments included collection 
of demographic information, such as age, gender, race and SES/household income, as 
well as a battery of widely-used self-report measures of stress-related psychological 
symptoms and health behaviors. Self-report measures included the DASH diet diary 
(Appendix A), the Stanford 7-Day Physical Activity Recall Scale (Appendix B), and an 
assessment of health behaviors including smoking and alcohol intake, among others. 
Trait mindfulness. Trait mindfulness was assessed via two scales. The first 
measure, the Five Facet Mindfulness Questionnaire (FFMQ; Appendix C), is a widely 
utilized 39-item gauge of trait mindfulness with questions distributed amongst five core 
facets including: Observing (8 items; α = .810), Describing (8 items; α = .874), Non-
Judgment (8 items; α = .934), Non-Reactivity (7 items; α = .881), and Acting with 
Awareness (8 items; α = .902).  Questions on the FFMQ lie on a five-point Likert scale, 
ranging from one (never or very rarely true) to five (very often or always true). The 
FFMQ can be scored as a single total or by subscales, examining each facet individually 
(Gu et al., 2016). The second measure was the Decentering subscale of the Experiences 
Questionnaire (EQ; Appendix D), an 11-question self-report measure of another core 
feature of mindfulness- Decentering, or viewing experiences and perceptions objectively 
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without over-identifying with them (α = .792). Higher scores on the FFMQ and the 
Decentering subscale of the EQ indicate higher trait mindfulness (Baer, Smith, Hopkins, 
Krietemeyer & Toney, 2006; Fresco et al., 2007). Both measures have adequate construct 
validity in adult samples (Goldberg et al., 2016; Fresco et al., 2007). 
Interventions 
Intervention descriptions were adapted from the Serenity Study grant application 
(NCT02371317). 
Lifestyle modification. All eligible study participants received lifestyle 
modification advice consistent with JNC-7 recommendations for prehypertension, via an 
American Heart Association brochure (titled “Understanding and Controlling Your High 
Blood Pressure”) handed out to participants and briefly reviewed by a study staff 
member (American Heart Association, 2003). Specifically, patients were advised to lose 
weight if they were overweight, eat a healthy diet high in fruits and vegetables and low in 
saturated fat, cholesterol and salt, increase physical activity, and limit alcohol to no more 
than one drink each day for women and no more than two drinks a day for men. 
Mindfulness based stress reduction (MBSR). The traditional MBSR training 
was based on the current curriculum developed by Drs. Saki Santorelli and Jon Kabat-
Zinn (Santorelli & Kabat-Zinn, 2009). MBSR instructors (trained by Drs. Kabat-Zinn and 
Santorelli) followed the standard 8-week program, session-by-session. The MBSR 
program includes eight 2.5-hour weekly group sessions, in which participants were 
instructed in three core mindfulness meditation exercises: sitting meditation, body scan, 
and gentle mindful yoga. All meditation practices were designed to cultivate a decentered 
perspective, by paying attention to one’s present-moment experience in a non-judging, 
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non-reactive, allowing way. For example, in all mindfulness exercises, participants focus 
their attention on the target of observation and remain aware of it in each moment. When 
thoughts, emotions, or sensations arise, they were observed nonjudgmentally, without 
having to change anything. With practice, MBSR training participants come to see that 
most sensations, thoughts, and emotions are transient and do not require a deliberate 
attempt to suppress them or change them. Outside of the weekly class sessions, MBSR 
training participants were expected to practice formal mindfulness meditation exercises at 
home at least 45 minutes per day, six days per week. They were also encouraged bring 
mindfulness to everyday activities (e.g., eating, walking, driving, communicating with 
others). In Week 6, the class met for a Day of Mindfulness silent retreat, guided by the 
MBSR instructor. The full-day (9am-4pm) retreat provided a unique opportunity to 
practice being mindful continuously, as a community devoted to living more mindfully. 
MBSR instructors encouraged class participants to apply what they learn through 
practicing mindfulness to their everyday life and behavior, with the common goal of 
lowering BP by better controlling reactions acute stress and making conscious decisions 
to maintain healthy lifestyle behaviors in the face of chronic stress. MBSR training 
participants were also invited to attend subsequent Days of Mindfulness during the study. 
Finally, to maximize relevance and engagement for study patients with prehypertension, 
didactic material on emotions, stress physiology, coping, communication styles, and 
everyday examples of mindless “autopilot” behavior, such as overeating, overworking, 
having too much “screen time”, avoiding exercise, and cutting back on sleep, were 
presented in the context of high BP. 
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Stress management education (SME). SME is an 8-week, group-based 
psychoeducational program designed to serve as an active control intervention for MBSR 
training (Hodge et al., 2013). SME is intended to provide equipoise for the non-specific 
elements of MBSR training without any of the putative active ingredients (e.g., 
mindfulness, yoga, etc.). Like MBSR training, SME patients learn about how stress 
affects health, participate in a supportive social environment, receive attention from a 
course instructor, hold a positive expectancy for healthy change, and engage in light 
physical exercise. SME also has the same in-class and home exercise time as the MBSR 
program, including a “Day of Stress Management” in the 6th week of SME, paralleling 
the “Day of Mindfulness” meditation retreat in MBSR training. SME also matches 
MBSR training for core elements of didactic content on how stress relates to eating 
patterns and nutrition, exercise, sleep, and time management. Time devoted to in-session 
educational activities and group discussion is also matched. 
Wait-list control (WLC). Pre-hypertensive patients randomly assigned to the 
WLC condition engaged in BP and laboratory stress assessments concomitant with 
patients in the MBSR training or SME arms. After the post-intervention assessment, 
WLC participants were invited to participate in their choice of MBSR training or SME, 
based on their personal preference. Mid-treatment, post-intervention, and 6- and 12-
month follow-up assessments were then conducted for WLC participants during their 
active interventions. 
Data Analyses 
Outcome measures included clinic SBP and DBP, ambulatory SBP and DBP, as 
well as SBP and DBP reactivity to stress. Clinic BP was calculated by averaging three BP 
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readings following standard AHA protocol (Pickering et al., 2005). Ambulatory BP was 
calculated by averaging all valid readings obtained during daytime and nighttime, to 
compute separate daytime and nighttime means (Hughes, 2013). BP reactivity to stress 
was calculated by subtracting a participant’s mean BP score (derived across five BP 
readings) during the baseline rest period from their mean BP score (derived across five 
BP readings) during the anger recall task. Descriptive statistics were performed via SPSS 
23 software. The variables of interest and their residuals were screened for violations of 
relevant statistical assumptions, as well as outliers and missing data, prior to formal 
analyses. Missing data were imputed via multiple imputation in both SPSS 23 and R. 
Internal consistency of measures utilized were examined via Cronbach’s alphas. To 
correct for multiple comparisons, a familywise alpha adjustment was applied to the alpha 
level for traditional statistical significance tests (p = .05 divided by a family of six 
primary outcome measures [clinic SBP and DBP; ambulatory SBP and DBP; reactivity 
SBP and DBP], resulting in α=.008; Holland & Copenhaver, 1987). 
Aim 1 data analyses. At baseline, does higher trait mindfulness relate to lower 
BP after controlling for known covariates of BP, and does this relationship differ as a 
function of demographics (race, age, gender and SES)? We predict that higher trait 
mindfulness relates to lower BP, and that this relationship remains consistent across 
demographics, as trait mindfulness emphasizes skills that are theoretically inherently 
accessible to all people. To answer this research question, we used baseline data (n=296) 
from the ongoing RCT, the Serenity Study (NCT02371317), including participants in the 
RCT and OL groups (n=296). First, we tested if higher trait mindfulness related to lower 
BP after controlling for known covariates of BP via hierarchical multiple regression. The 
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first step of the model included known covariates of BP collected during the trial, 
including BMI, smoking history, risky alcohol use, healthy diet, hours exercised weekly, 
and hours slept daily, as well as dummy-coded demographic characteristics with known 
CVD and BP disparities-- race, age, gender and SES. The second step of the model had a 
trait mindfulness variable (Observing, Describing, Acting with Awareness, Nonjudging, 
Nonreactivity, or Describing). All continuous predictor variables were centered. This 
model was repeated across SBP and DBP in clinic BP, ambulatory BP, and BP reactivity, 
for each trait mindfulness facet, for a total of 36 models, each showing how a trait 
mindfulness facet predicted a form of BP. However, the ambulatory BP and BP reactivity 
analyses included fewer BP covariates due to smaller sample size and less statistical 
power. BP covariates used for these analyses included BMI, alongside the demographic 
categories linked with BP (see Tables 2-3). These relationships were interpreted via 
unstandardized regression coefficients (B) and associated p-values.  
To answer if the relationship between trait mindfulness and BP differs as a 
function of demographics, we ran moderation analyses predicting the different forms of 
BP (clinic BP, ambulatory BP, BP reactivity) within the same sample. Model 
comparisons between a full model, including covariates of BP and demographic 
characteristics linked with BP, a single trait mindfulness variable (for example, 
Observing), and interaction terms between that trait mindfulness variable and 
demographic characteristics (for example, including the interaction terms between 
Observing and Race, Observing and Gender, Observing and Age, Observing and SES, 
etc.) and a reduced model, which dropped the trait mindfulness/demographic interaction 
terms, elucidated if the relationship between individual trait mindfulness facets and BP 
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differed as a function of demographics. R2 difference significance was measured via p-
values, and model selection validity was evaluated via BIC and BF. If the R2 difference 
between the full and reduced models reached alpha adjusted significance, it was 
interpreted as the relationship between that specific trait mindfulness facet and BP 
differing as a function of demographics, as the interactions would explain an increased 
proportion of variance in BP compared against the reduced model without interactions. 
BIC and BF were included as metrics to identify occurrence of model overfitting 
potentially causing the appearance of demographic differences in the relationship 
between trait mindfulness facets and BP with even small increases in variance explained 
(Kass & Raftery, 1995). The R package ‘dustinfife/fifer’, and function 
‘impute.model.comparison’, were used to complete the multiple imputation and model 
comparisons, including R2 p-value, Bayesian Information Criterion (BIC) and Bayes 
Factor (BF) as metrics, using the imputed data. 
Power analyses were completed with G*Power 3.1 software. For a multiple 
regression assuming an alpha level of .05 and power of .95, the necessary sample size 
was 292 participants. The final sample size used in the clinic BP analyses was 296 
participants, including RCT and OL participants. However, the final sample for 
ambulatory BP and BP reactivity to stress were underpowered to detect smaller effects, 
with sample sizes of 94 and 152, respectively, including only RCT participants.  
Aim 2 data analyses. Does MBSR training lower BP, and does it do so across 
subgroups and initial levels of trait mindfulness? Due to low sample size (n=44), we 
treated this aim as a ‘pilot’ analysis, using pre-post data from the Serenity Study 
(NCT02371317). Specifically, we included RCT participants randomized to the MBSR 
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training group across sites, and calculated the clinic BP pre-post mean difference in the 
whole sample and within each subgroup. Effect size (ES) calculated using Hedges’ G for 
paired samples was the primary metric of choice, as Hedges’ G natively corrects for 
errors generated by small sample sizes (Borenstein, Hedges, Higgins & Rothstein, 2011). 
One prior meta-analysis of 8,500 participants with high BP found that an ES of .235 
equaled a SBP change of 3 mmHg (Conn, Ruppar & Chase, 2016). A small negative (-
.235) ES of MBSR training on BP was therefore understood as potentially clinically 
relevant, if the confidence intervals (CIs) did not contain zero (Hagins, States, Selfe & 
Innes, 2013; Appel et al., 2006). Although the predicted changes were modest, they are 
similar in scale to other health behavior modifying therapies for high blood pressure, and 
are considered clinically relevant for people with prehypertension (Whelton et al., 2002). 
Differences in intervention ES between demographic subgroups were compared by 
calculating 95% CIs for each subgroup ES. If the 1) the CIs of the relevant ES did not 
contain zero, and 2) the CIs had at or under a quarter of overlap across demographic 
subgroups, the CI differences were interpreted as significant between the two ESs (Belia, 
Fidler, Williams & Cumming, 2005; McGough & Faraone, 2009).  
Aim 3 data analyses. Finally, are changes in trait mindfulness facets and BP 
following MBSR training correlated, and do these correlations occur across different 
subgroups (age, gender, race, SES) and different initial levels of trait mindfulness? Due 
to low sample size, we treated this as a ‘pilot’ analysis, and using pre-post data from the 
Serenity Study (NCT02371317), calculated correlations between change in trait 
mindfulness facets after MBSR training and change in mean clinic BP after MBSR 
training for each subgroup. Correlation coefficient ES was the primary metric of choice, 
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and moderate (-.3) ESs with CIs not containing zero were understood as a potentially 
meaningful link between changes in specific trait mindfulness facets and changes in BP 
following MBSR training. Again, differences in correlation coefficient ES between 
demographic subgroups were compared by calculating 95% CIs for each subgroup ES. If 
the 1) the Cis of the relevant ES did not contain zero, and 2) the CIs had at or under a 
quarter of overlap across demographic subgroups, the CI differences were interpreted as 
significant between the two ESs.  
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Chapter Three 
 
Results 
 Results 
Aim 1. At baseline, does higher trait mindfulness relate to lower BP after 
controlling for known covariates of BP, and does this relationship differ as a function of 
demographics (race, age, gender and SES)? 
Separate regressions were conducted for SBP and DBP for each type of BP 
(Clinic BP, ambulatory BP, and BP reactivity to stress), predicting SBP or DBP from one 
of six facets of trait mindfulness at a time in separate regression models: Observing, 
Describing, Acting with Awareness, Nonjudging, Nonreactivity, and Decentering. Within 
clinic BP, ambulatory BP, and BP reactivity to stress, after controlling for covariates of 
BP, no mindfulness facets significantly related to BP, overall indicating a null 
relationship between BP and trait mindfulness. 
Model comparisons showed that the relationship between trait mindfulness and 
BP did appear to differ as a function of demographics in some but not all facets. Within 
clinic BP, the reduced models accounted for relatively small amounts of variance in BP. 
However, the full models, with interaction terms added to account for potential 
demographic differences, showed small but significant increases in variance explained 
for SBP for Observing and Nonjudging, and for DBP for Acting with Awareness and 
Nonjudging, based on R2 difference p-values, as shown in Table 2. Yet, when taken 
together with the BIC and BF favoring the reduced models—an indication that they may 
be more efficient— a plausible interpretation is that overfitting may have generated the 
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appearance of demographic differences in the relationship between trait mindfulness 
facets and clinic BP. 
 
 
Table 2 
Results of the Clinic BP Model Comparisons For Each Trait Mindfulness Facet (n=296) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Observing Facet DV=DBP; Observing Facet 
Full 0.097 -31345.060 6.95E+26 <.001 0.035 -17385.400 3.63E+26 0.986 
Reduced 0.088 -31468.670     0.035 -17507.710     
 DV=SBP; Describing Facet DV=DBP; Describing Facet 
Full 0.093 -31526.030 1.23E-107 1.000 0.045 -17173.450 9.59E+48 0.070 
Reduced 0.092 -31033.700     0.040 -17399.020     
 DV=SBP; Acting with Awareness Facet DV=DBP; Acting with Awareness Facet 
Full 0.091 -31578.050 4.96E+38 0.119 0.055 -17044.740 1.99E+98 <.001 
Reduced 0.085 -31756.250     0.036 -17497.420     
 DV=SBP; Nonjudging Facet DV=DBP; Nonjudging Facet 
Full 0.116 -30279.430 3.63E+151 <.001 0.059 -17053.210 1.02E+29 <.001 
Reduced 0.107 -30977.390     0.047 -17186.790     
 DV=SBP; Nonreactivity Facet DV=DBP; Nonreactivity Facet 
Full 0.082 -31721.550 634281.6 0.660 0.035 -17493.790 3.98E-29 1.000 
Reduced 0.080 -31748.270     0.035 -17363.000     
 DV=SBP; Decentering DV=DBP; Decentering 
Full 0.089 -31330.290 2.36E+37 0.087 0.042 -17551.810 5.62E-10 0.019 
Reduced 0.081 -31502.390     0.033 -17509.210     
 
 
 
Within Ambulatory BP, the reduced models again accounted for small amounts of 
variance in BP. In comparison, the full models showed small but significant increases in 
variance explained for both SBP and DBP in Observing, Describing, Acting with 
Awareness and Nonjudging, and for just DBP in Decentering, as shown in Table 3. 
Again, when considering the metrics altogether, it is plausible that the appearance of 
demographic differences in the relationship between trait mindfulness facets and clinic 
  
 
 
29 
 
BP based on R2 difference p-values resulted from overfitting, as the BIC and BF metrics 
favored the reduced models. 
 
 
Table 3 
Results of the Ambulatory BP Model Comparisons For Each Trait Mindfulness Facet (n=96) 
Model R2 BIC BF P R2 BIC BF P 
  DV=SBP; Observing Facet DV=DBP; Observing Facet 
Full 0.065 -11386.800 3.75E+67 <.001 0.145 -7196.167 8.31E+78 <.001 
Reduced 0.036 -11698.000   0.097 -7559.605   
  DV=SBP; Describing Facet DV=DBP; Describing Facet 
Full 0.107 -10089.610 1.00E+210 <.001 0.158 -7193.794 5.20E+142 <.001 
Reduced 0.035 -11056.710   0.084 -7851.026   
  DV=SBP; Acting with Awareness Facet DV=DBP; Acting with Awareness Facet 
Full 0.066 -10955.560 1.04E+62 <.001 0.145 -7345.234 3.05E+123 <.001 
Reduced 0.037 -11241.160   0.108 -7913.900   
  DV=SBP; Nonjudging Facet DV=DBP; Nonjudging Facet 
Full 0.152 -10108.610 3.08E+237 <.001 0.159 -7079.928 2.08E+210 <.001 
Reduced 0.034 -11202.280   0.089 -8048.475   
  DV=SBP; Nonreactivity Facet DV=DBP; Nonreactivity Facet 
Full 0.053 -10818.520 8.93E+93 1.000 0.098 -7812.671 4.50E+32 1.000 
Reduced 0.052 -11251.180   0.096 -7963.044   
  DV=SBP; Decentering DV=DBP; Decentering 
Full 0.052 -11021.470 2.05E+109 0.061 0.146 -7204.571 2.93E+127 <.001 
Reduced 0.044 -11524.870   0.100 -7791.575     
 
 
 
Within BP reactivity, the reduced models similarly accounted for a small amount 
of variance in BP reactivity to stress. In comparison, the full models accounting for 
demographic differences again showed small but significant increases in variance 
explained for SBP and DBP for Acting with Awareness and Nonjudging, for just SBP in 
Nonreactivity and Decentering, and for just DBP in Observing and Describing, as shown 
in Table 4. Still, with all metrics taken together, as the BIC and BF favored the reduced 
models, it is plausible that the appearance of demographic differences in the relationship 
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between trait mindfulness facets and BP reactivity based on R2 difference p-values 
resulted from overfitting. 
 
  
Table 4 
Results of the BP Reactivity Model Comparisons For Each Trait Mindfulness Facet (n=152) 
Model R2 BIC BF P R2 BIC BF P 
  DV=SBP; Observing Facet DV=DBP; Observing Facet 
Full 0.066 -11537.530 1650.897 0.983 0.040 -5294.515 1.99E+45 <.001 
Reduced 0.063 -11552.350   0.016 -5503.121   
  DV=SBP; Describing Facet DV=DBP; Describing Facet 
Full 0.075 -11586.120 2.66E-20 0.014 0.040 -5406.505 5.42E+21 <.001 
Reduced 0.061 -11495.970   0.015 -5506.594   
  DV=SBP; Acting with Awareness Facet DV=DBP; Acting with Awareness Facet 
Full 0.129 -10970.900 3.92E+73 <.001 0.055 -5213.006 5.50E+52 <.001 
Reduced 0.079 -11309.810   0.014 -5455.886   
  DV=SBP; Nonjudging Facet DV=DBP; Nonjudging Facet 
Full 0.124 -11007.930 1.33E+28 <.001 0.142 -4627.348 1.41E+119 <.001 
Reduced 0.093 -11137.450   0.060 -5176.047   
  DV=SBP; Nonreactivity Facet DV=DBP; Nonreactivity Facet 
Full 0.088 -11162.860 1.55E+64 <.001 0.022 -5369.602 6.20E+28 0.162 
Reduced 0.076 -11458.460   0.017 -5502.195   
  DV=SBP; Decentering DV=DBP; Decentering 
Full 0.098 -11232.620 1.64E+15 <.001 0.026 -5407.251 5.88E+16 0.290 
Reduced 0.079 -11302.690 
  
0.018 -5484.477     
 
 
 
In summary, although trait mindfulness and BP do not seem to relate before 
accounting for potential demographic differences, a small but significantly increased 
amount of variance in BP was explained by some trait mindfulness facets when the 
interactions between trait mindfulness and demographic variables were added as the third 
step of the model. Still, as shown in Tables 2-4 the BIC and BF metrics overwhelmingly 
favored the reduced models, indicating that although accounting for potential 
demographic differences generated small improvements to model fit, said improvements 
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may result from model overfitting inflating the R2 metric (Kass & Raftery, 1995). These 
results imply that the relationship between some trait mindfulness facets and BP may 
differ slightly but significantly across demographic groups. However, 1) due to the 
number of predictors and the BIC and BF favoring the reduced models, it was unclear if 
overfitting generated these results, and 2) it was indeterminable if specific demographics 
were driving these possible moderating effects as all four demographic interactions being 
included simultaneously. 
Aim 1 exploratory analyses. Therefore, to determine if specific demographics 
drove observed significant differences within the model comparisons described as the 
main results of Aim 1, we tested a single demographic at a time. To do so, we utilized 
exploratory model comparisons between full models, in this case including covariates of 
BP, the relevant trait mindfulness variable and a single interaction term between that trait 
mindfulness variable and one demographic at a time, and reduced models, excluding the 
interaction term. Within each trait mindfulness facet that was previously found to vary in 
its relationship with BP as a function of demographics, the alpha adjusted p-values 
(α=.008) were used to determine if the full model accounted for significantly more 
variance than the reduced. BIC and BF were again utilized to identify occurrence of 
model overfitting causing the appearance of demographic differences in the relationship 
between trait mindfulness facets and BP with even small increases in variance explained 
(Kass & Raftery, 1995). If a full model with a single demographic both reached statistical 
significance via R2 difference p-value, and was favored by the BIC and BF compared 
against a reduced model, it was interpreted as responsible for the earlier observed 
demographic differences in the relationship between that trait mindfulness facet and BP. 
  
 
 
32 
 
Table 5 
Results of the Clinic BP Model Comparisons For Observing (n=296) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.094 -30787.660 3.67E+163 <.001 0.035 -17457.420 6.64E+12 1.000 
Reduced 0.085 -31540.900     0.035 -17516.470     
 DV=SBP; Age DV=DBP; Age 
Full 0.091 -31417.460 8.46E+02 1.000 0.035 -17592.730 5.50E-18 0.047 
Reduced 0.089 -31430.940     0.035 -17513.250     
      DV=SBP; Gender DV=DBP; Gender 
Full 0.086 -31877.910 4.85E-82 0.477 0.034 -17436.450 1.33E+31 1.000 
Reduced 0.087 -31503.450     0.034 -17579.780     
 DV=SBP; SES DV=DBP; SES 
Full 0.091 -31269.340 8.20E-44 0.016 0.037 -17480.710 62563383947 0.300 
Reduced 0.089 -31070.920     0.034 -17530.430     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
 
 
 
In clinic BP, the relationship between the Observing facet and SBP seemed to 
vary significantly as a function of race based on the R2 difference p-values though the 
BIC and BF favored the reduced model as more efficient, shown in Table 5. The 
relationship between Observing and DBP did not appear to differ across demographics. 
The relationship between Describing and BP did not differ across demographics.  
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Table 6 
Results of the Clinic BP Model Comparisons For Acting with Awareness (n=296) 
Model R2 BIC BF P R2 BIC BF P 
  DV=SBP; Race DV=DBP; Race 
Full 0.085 -31455.210 2.54E+40 0.039 0.038 -17445.580 7.97E-08 1.000 
Reduced 0.083 -31641.280     0.037 -17412.890     
  DV=SBP; Age DV=DBP; Age 
Full 0.085 -31747.870 3.25E-32 1.000 0.045 -17367.720 1.04E+26 0.004 
Reduced 0.086 -31602.860     0.036 -17487.530     
  DV=SBP; Gender DV=DBP; Gender 
Full 0.086 -31437.010 2.90E+53 1.000 0.045 -17280.930 1.13E+49 <.001 
Reduced 0.084 -31683.200     0.037 -17506.830     
  DV=SBP; SES DV=DBP; SES 
Full 0.089 -31554.980 1.41E+25 0.019 0.042 -17249.850 8.23805E+60 0.073 
Reduced 0.082 -31670.800     0.037 -17530.380     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
 
 
 
The relationship between Acting with Awareness and SBP did not differ across 
demographics. Based on the R2 difference p-values, the relationship between Acting with 
Awareness and DBP seemed to differ as a function of both age and gender, though the 
BIC and BF indicated the reduced models as more efficient, shown in Table 6. 
 
 
 
 
 
 
 
 
  
 
 
34 
 
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
 
 
 
Based on the R2 difference p-values, the relationship between Nonjudging and BP 
appeared to differ as a function of race across SBP and age across DBP, and the BIC and 
BF concurrently slightly favored the full model in race across SBP, but not in age across 
DBP, shown in Table 7.  The relationship between Nonreactivity and BP, or Decentering 
and BP, did not differ across demographics.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7 
Results of the Clinic BP Model Comparisons For Nonjudging (n=296) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.110 -30734.150 6.14E-11 <.001 0.052 -17078.820 9.35E+48 0.043 
Reduced 0.107 -30687.120     0.048 -17304.340     
 DV=SBP; Age DV=DBP; Age 
Full 0.107 -30607.620 1.17E-42 1.000 0.050 -17295.930 3.95E+09 0.001 
Reduced 0.105 -30414.520     0.048 -17340.130     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.107 -30578.690 5.08E+35 0.258 0.050 -17268.040 5.33E+09 1.000 
Reduced 0.105 -30743.120     0.050 -17312.840     
 DV=SBP; SES DV=DBP; SES 
Full 0.110 -30456.000 9.34E+55 0.054 0.051 -17189.900 1.69192E-16 0.057 
Reduced 0.106 -30713.750     0.049 -17117.270     
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Table 8 
Results of the Ambulatory BP Model Comparisons For Observing (n=94) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.034 -11222.770 5.63E-13 1.000 0.102 -7792.974 1.55E-38 1.000 
Reduced 0.035 -11166.360     0.107 -7618.861     
 DV=SBP; Age DV=DBP; Age 
Full 0.036 -11578.070 2.26E+18 1.000 0.112 -7837.483 2.61E-01 1.000 
Reduced 0.034 -11662.590     0.099 -7834.794     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.055 -11385.810 5.84E-51 <.001 0.118 -7687.497 5.32E+37 <.001 
Reduced 0.035 -11154.470     0.094 -7861.230     
 DV=SBP; SES DV=DBP; SES 
Full 0.037 -11725.370 3.14E-127 1.000 0.100 -7924.594 2.4355E-74 0.294 
Reduced 0.034 -11142.800     0.098 -7585.592     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
 
 
 
In ambulatory BP, the relationship between the Observing facet and BP appeared 
to differ as a function of gender across both SBP and DBP based on the R2 difference p-
values, and the BIC and BF concurrently slightly favored the full model in SBP but not 
DBP, shown in Table 8. 
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Table 9 
Results of the Ambulatory BP Model Comparisons For Describing (n=94) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.043 -11523.620 2.47E-88 1.000 0.092 -7781.495 2.34E+25 0.003 
Reduced 0.037 -11120.180     0.091 -7898.321     
 DV=SBP; Age DV=DBP; Age 
Full 0.035 -11696.420 1.51E-102 1.000 0.126 -7529.617 6.02E+77 <.001 
Reduced 0.036 -11227.510     0.087 -7887.805     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.085 -11144.210 8.16E-23 0.001 0.093 -7974.978 1.41E-84 0.403 
Reduced 0.034 -11042.490     0.092 -7588.824     
 DV=SBP; SES DV=DBP; SES 
Full 0.042 -11038.580 3.34E+25 1.000 0.126 -7673.483 39.92609 0.006 
Reduced 0.037 -11156.120     0.086 -7680.857     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP 
did NOT differ across demographics. Bold denotes significance, α=.008 
 
 
 
Based on the R2 difference p-values, the relationship between the Describing facet 
and SBP differed again as a function of gender, and the BIC and BF concurrently slightly 
favored the full model, while in DBP, it differed as a function of race, age, and SES, 
though the BIC and BF favored the reduced models, shown in Table 9. 
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Based on the R2 difference p-values, the relationship between Acting with 
Awareness and BP differed as a function of Race and SES across both SBP and DBP, and 
the BIC and BF concurrently slightly favored the full models in each of these potential 
demographic differences except for in SES across DBP, shown in Table 10. 
 
 
 
 
 
 
 
 
 
Table 10 
  Results of the Ambulatory BP Model Comparisons For Acting with Awareness (n=94)   
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.041 -11227.630 7.45E-44 0.003 0.111 -7802.959 1.06E-08 0.003 
Reduced 0.037 -11029.020     0.105 -7766.229     
 DV=SBP; Age DV=DBP; Age 
Full 0.037 -11068.170 9.90E+133 1.000 0.107 -7716.173 1.17E+13 0.256 
Reduced 0.037 -11685.240     0.106 -7776.348     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.042 -11015.400 6.82E+24 1.000 0.104 -7641.384 2.55E+18 1.000 
Reduced 0.037 -11129.770     0.102 -7726.147     
 DV=SBP; SES DV=DBP; SES 
Full 0.046 -11722.160 2.90E-54 0.001 0.134 -7446.191 1.47632E+67 0.001 
Reduced 0.036 -11475.610     0.101 -7755.516     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did NOT 
differ across demographics. Bold denotes significance, α=.008 
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Based on the R2 difference p-values, the relationship between Nonjudging and BP 
differed as a function of SES across both SBP and DBP, and additionally differed across 
race and gender in only SBP, while the BIC favored the reduced models, shown in Table 
11. The relationship between Nonreactivity and BP did not differ as a function of 
demographics.  
 
 
Table 11 
Results of the Ambulatory BP Model Comparisons For Nonjudging (n=94) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.063 -10742.120 2.70E+67 <.001 0.105 -7698.167 3.06E+25 1.000 
Reduced 0.034 -11052.650     0.096 -7815.535     
 DV=SBP; Age DV=DBP; Age 
Full 0.035 -11717.100 8.82E-117 1.000 0.105 -7714.419 1.98E+44 1.000 
Reduced 0.033 -11182.650     0.095 -7918.408     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.070 -10833.320 1.13E+214 <.001 0.096 -7907.680 8.45E-13 0.014 
Reduced 0.034 -11819.070     0.090 -7852.081     
 DV=SBP; SES DV=DBP; SES 
Full 0.093 -11084.280 1.68E+66 <.001 0.149 -7146.706 1.4664E+159 <.001 
Reduced 0.035 -11389.260     0.093 -7879.694     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
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The relationship between Decentering and SBP did not differ as a function of 
demographics, and although earlier analyses indicated that the relationship between 
Decentering and DBP may differ as a function of demographics, no individual 
demographic interactions significantly explained more variance in BP when comparing 
the full and reduced model R2. Furthermore, the BIC and BF favored the reduced models 
in all cases but SES, shown in Table 12. 
 
 
 
 
 
 
 
Table 12 
Results of the Ambulatory BP Model Comparisons For Decentering (n=94) 
Model R2 BIC BF P R2 BIC BF P 
  DV=SBP; Race DV=DBP; Race 
Full 0.043 -10924.980 3.31E+08 0.003 0.108 -7739.156 6.38E+08 1.000 
Reduced 0.042 -10964.220     0.097 -7779.703     
  DV=SBP; Age DV=DBP; Age 
Full 0.042 -11738.690 1.89E-123 0.262 0.149 -7398.757 1.25E+136 1.000 
Reduced 0.041 -11173.530     0.099 -8025.509     
  DV=SBP; Gender DV=DBP; Gender 
Full 0.045 -11061.020 1.16E+104 0.010 0.103 -7664.356 4.30E+34 0.129 
Reduced 0.042 -11540.250     0.096 -7823.848     
  DV=SBP; SES DV=DBP; SES 
Full 0.049 -11091.560 2.00E+69 0.021 0.109 -7829.468 3.0365E-06 0.328 
Reduced 0.041 -11410.700     0.101 -7804.058     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
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In BP reactivity to stress, the relationship between the Observing facet and SBP 
reactivity did not differ across demographics, while the relationship between Observing 
and DBP reactivity appeared to differ as a function of race, age, and gender based on the 
R2 difference p-values, though the BIC and BF still favored the reduced models, shown in 
Table 13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 13 
Results of the BP Reactivity Model Comparisons For Observing (n=152) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.063 -11448.470 1.99E+19 0.160 0.022 -5439.088 7.04E+16 <.001 
Reduced 0.062 -11537.340     0.017 -5516.675     
 DV=SBP; Age DV=DBP; Age 
Full 0.063 -11534.180 1.46E+13 1.000 0.022 -5445.172 4.93E+17 <.001 
Reduced 0.062 -11594.810     0.015 -5526.653     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.064 -11526.460 3.88E+14 0.004 0.020 -5453.444 1.52E+24 <.001 
Reduced 0.062 -11593.650     0.016 -5564.809     
 DV=SBP; SES DV=DBP; SES 
Full 0.063 -11549.850 4.04E+40 0.200 0.027 -5426.326 1.41942E+18 0.086 
Reduced 0.061 -11736.850     0.015 -5509.919     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
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Based on the R2 difference p-values, the relationship between Describing and SBP 
reactivity appeared to differ as a function of race, and the BIC and BF concurrently 
slightly favored the full model, shown in Table 14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14 
Results of the BP Reactivity Model Comparisons For Describing (n=152) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.063 -11494.960 5.99E+20 1.000 0.022 -5545.621 4.66E-07 0.002 
Reduced 0.062 -11590.640     0.015 -5516.461     
 DV=SBP; Age DV=DBP; Age 
Full 0.064 -11516.800 1.62E+09 0.032 0.028 -5390.455 1.02E+22 1.000 
Reduced 0.062 -11559.210     0.017 -5491.810     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.071 -11424.960 1.73E+39 0.016 0.017 -5479.768 6.62E+13 0.425 
Reduced 0.062 -11605.660     0.017 -5543.416     
 DV=SBP; SES DV=DBP; SES 
Full 0.066 -11434.800 5.25E+26 0.152 0.023 -5469.174 5.73089E-07 0.267 
Reduced 0.063 -11557.850     0.017 -5440.429     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
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Table 15 
Results of the BP Reactivity Model Comparisons For Acting with Awareness (n=152) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.080 -11422.060 3.01E+06 0.005 0.034 -5421.057 2.84E+15 1.000 
Reduced 0.079 -11451.900     0.015 -5492.221     
 DV=SBP; Age DV=DBP; Age 
Full 0.092 -11109.210 9.16E+26 <.001 0.015 -5425.685 3.40E+02 1.000 
Reduced 0.081 -11233.370     0.015 -5437.342     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.094 -10953.920 3.06E+64 <.001 0.014 -5485.268 1.63E+07 0.542 
Reduced 0.080 -11250.890     0.014 -5518.477     
 DV=SBP; SES DV=DBP; SES 
Full 0.095 -11099.750 1.31E+39 0.011 0.042 -5229.218 4.37151E+57 0.029 
Reduced 0.081 -11279.890     0.015 -5494.663     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
 
 
 
Based on the R2 difference p-values, the relationship between Acting with 
Awareness and BP reactivity appeared to differ as a function of race, age, and gender 
across SBP, though the BIC and BF still favored the reduced models. Although earlier 
analyses indicated that the relationship between Acting with Awareness and DBP may 
differ as a function of demographics, no individual demographic interactions significantly 
explained more variance in BP when comparing the full and reduced model R2, shown in 
Table 15. 
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Table 16 
Results of the BP Reactivity Model Comparisons For Nonjudging (n=152) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.113 -10789.620 3.36E+85 <.001 0.084 -5215.008 6.63E-08 <.001 
Reduced 0.092 -11183.480     0.056 -5181.950     
 DV=SBP; Age DV=DBP; Age 
Full 0.094 -11116.120 2.02E+37 0.047 0.068 -5163.083 1.19E+03 <.001 
Reduced 0.092 -11287.920     0.062 -5177.250     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.101 -11043.310 1.63E+22 <.001 0.062 -5221.836 1.48E+02 0.009 
Reduced 0.094 -11145.600     0.056 -5231.824     
 DV=SBP; SES DV=DBP; SES 
Full 0.107 -10952.480 2.78E+43 <.001 0.098 -5056.884 1.08073E+21 <.001 
Reduced 0.091 -11152.550     0.058 -5153.748     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did NOT 
differ across demographics. Bold denotes significance, α=.008 
 
 
 
Based on the R2 difference p-values, the relationship between Nonjudging and BP 
reactivity appeared to differ as a function of race and SES across both SBP and DBP, 
gender in only SBP, and age in only DBP, though the BIC and BF favored the full model 
for only race across DBP, and favored the reduced model for all other comparisons, 
shown in Table 16. 
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Based on the R2 difference p-values, the relationship between Nonreactivity and 
SBP reactivity appeared to differ as a function of gender, and the BIC and BF 
concurrently favored the full model, shown in Table 17. The relationship between 
Nonreactivity and DBP reactivity did not differ across demographics. 
 
 
 
 
Table 17 
Results of the BP Reactivity Model Comparisons For Nonreactivity (n=152) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.081 -11353.120 1.96E+12 0.019 0.018 -5477.270 1.10E-10 1.000 
Reduced 0.075 -11409.720     0.017 -5431.408     
 DV=SBP; Age DV=DBP; Age 
Full 0.080 -11373.640 1.19E+14 0.069 0.018 -5505.541 2.46E-04 0.319 
Reduced 0.075 -11438.450     0.016 -5488.922     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.080 -11402.270 5.78E-23 <.001 0.016 -5450.295 1.46E+05 <.001 
Reduced 0.078 -11299.860     0.018 -5474.076     
 DV=SBP; SES DV=DBP; SES 
Full 0.077 -11415.460 9.06E-27 1.000 0.016 -5445.221 6572099809 0.164 
Reduced 0.076 -11295.530     0.015 -5490.433     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and 
BP did NOT differ across demographics. Bold denotes significance, α=.008 
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Based on R2 difference p-values, the relationship between Decentering and SBP 
reactivity seemed to differ as a function of age, though the BIC and BF still favored the 
reduced model, shown in Table 18. The relationship between Nonreactivity and DBP 
reactivity did not differ across demographics. 
Aim 2. Does MBSR training lower clinic BP, the AHA ‘gold standard’ BP 
measurement (Chobanian et al., 2003), and does it do so across different subgroups (age, 
gender, race, SES) and different initial levels of trait mindfulness? 
 
 
 
Table 18 
Results of the BP Reactivity Model Comparisons For Decentering (n=152) 
Model R2 BIC BF P R2 BIC BF P 
 DV=SBP; Race DV=DBP; Race 
Full 0.077 -11339.720 1.56E+06 1.000 0.021 -5484.373 2.98E-03 0.002 
Reduced 0.080 -11368.250     0.019 -5472.744     
 DV=SBP; Age DV=DBP; Age 
Full 0.088 -11236.650 2.09E+31 <.001 0.020 -5447.246 2.85E+05 0.387 
Reduced 0.080 -11380.890     0.019 -5472.367     
 DV=SBP; Gender DV=DBP; Gender 
Full 0.089 -11195.420 2.61E+22 0.011 0.023 -5439.144 1.56E-11 1.000 
Reduced 0.079 -11298.660     0.021 -5389.382     
 DV=SBP; SES DV=DBP; SES 
Full 0.084 -11340.430 6.48E-06 0.153 0.022 -5402.224 2.96287E+12 0.641 
Reduced 0.078 -11316.540     0.019 -5459.659     
Note: Blackened sections denote that the relationship between the trait mindfulness facet and BP did 
NOT differ across demographics. Bold denotes significance, α=.008 
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Figure 2. Heatmap of Hedges’ G effect size (ES) following the intervention. Brighter 
green indicates decreases in blood pressure (BP) following MBSR training, whereas 
brighter red indicates increases in BP. 
 
 
 
As the group sample sizes are particularly small, the following results should be 
viewed as preliminary and interpreted with caution. Among all participants randomized 
to MBSR training (n=44), change in SBP following MBSR training was negligible (.26 
mmHg, [-2.96, 3.02]; g = .00, [-.33, .34]). Change in DBP was in the direction 
anticipated but did not reach designated clinical relevance (-1.27 mmHg, [-3.19, .65]; g = 
-.18, [-.45, .09]). Among White participants (n=31), there was no effect on SBP, as the CI 
of the ES contained zero (-1.7 mmHg, [-5.63, 2.16]; g = -.179, [-.58, .215]), while the 
decrease in DBP reached designated clinically relevant ES (-2.38 mmHg, [-4.44, -.316]; g 
= -.35, [-.67, -.04]). Among Black participants (n=11), SBP increased, against our 
prediction (5.02 mmHg, [.25, 9.81]; g = .82, [.034, 1.7]), though there was no effect in 
DBP, as the CI of the ES contained zero (1.45 mmHg, [-4.26, 7.16]; g = .14, [-.46, .83]). 
Effect Sizes CI Effect Sizes
All MBSR Participants (n=44) Male Participants (n=24)
ΔSBP 0.00 -.33, .34  -0.11
ΔDBP -0.18 -.46, .09  -0.07
Black Participants (n=11) Female Participants (n=23)
ΔSBP 0.82 .03, 1.7  0.10
ΔDBP 0.14 -.46, .82 -0.35
White Participants (n=31) Lower SES Participants (n=24)
ΔSBP -0.18 -.58, .22 0.24
ΔDBP -0.35 -.67, -.04 -0.25
Younger Age Participants (n=11) Higher SES Participants (n=17)
ΔSBP 0.65 .05, 1.34 -0.30
ΔDBP 0.01 -.45, .47 -0.08
Middle Age Participants (n=21) Lower Initial Trait Mindfulness (n=16)
ΔSBP -0.32 -.84, .17 -0.18
ΔDBP -0.32 -.74, .08 -0.16
Older Age Participants (n=13) Higher Initial Trait Mindfulness (n=29)
ΔSBP -0.06 -.74, .61 0.21
ΔDBP -0.20 -.93, .49  -0.19
  
 
 
47 
 
The differences in intervention ES between Black and White race participants reached 
significance in SBP but not DBP, as the CIs of each group’s ES overlapped. 
In younger age participants (n=11), SBP increased, against our prediction (6.12 
mmHg, [.548, 11.7]; g = .65, [.05, 1.34]), while change in DBP was negligible (.09 
mmHg, [-4.98, 5.16]; g = .00, [-.45, .47]). In middle age participants (n=21), there was 
no effect in either SBP (-2.83 mmHg, [-7.27, 1.26]; g = -.32, [-.84, .17]) or DBP, (-2.1 
mmHg, [-4.78, .59]; g = -.32, [-.74, .08]), as the CI of the ES contained zero. Similar null 
results occurred in older age participants (n=13) across SBP (-.53 mmHg, [-6.55, 5.5]; g 
= -.06, [-.738, .609]), and DBP (-1.09 mmHg, [-5, 2.83]; g = -.2, [-.33, .34]). The 
differences in intervention ES between participants of younger, middle, and older age did 
not reach significance. 
Among male participants (n=22), there was no effect in either SBP (-.95 mmHg, 
[-5.44, 3.53]; g = -.11, [-.63, .4]) or DBP (-.59 mmHg, [-3.6, 2.42]; g = .07, [-.41, .27]). 
Similar null effects occurred among female participants (n=23), with no effect in either 
SBP (.96 mmHg, [-3.34, 5.27]; g = .1, [-.34, .55]), or DBP (-1.92 mmHg, [-4.55, .71]; g 
= -.354, [-.852, .124]), as the CIs of the ESs contained zero. Differences in ES across 
male and female gender participants did not reach significance.  
In lower SES participants (n=24, household income < $75,000) there was no 
effect in SBP (2.27 mmHg, [-2.2, 6.74]; g = .239, [-.22, .717]), or DBP (-1.92 mmHg, [-
4.8, .95]; g = -.25, [-.63, .118]), as the CIs of the ESs contained zero. In higher SES 
participants (n=17, household income > $75,000), there was no effect of SBP (-2.67 
mmHg, [-7.35, 2.03]; g = -.297, [-.83, .21]) or DBP (-.51 mmHg, [-3.57, 2.55]; g = -.08, 
[-.56, .387]), as the CIs of the ESs contained zero. Differences in intervention ES across 
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lower and higher SES did not reach significance. Among participants with lower initial 
trait mindfulness (n=16, trait mindfulness at or below meditation-naive population mean), 
there were no effects of SBP (-1.95 mmHg, [-7.26, 3.34]; g = -.18, [-.67, .29]), or DBP (-
1.4 mmHg, [-5.28, 2.49]; g = -.16, [-.62, .28]), as the CIs of the ESs contained zero.  
Similar null results were found among participants with higher initial trait 
mindfulness (n=29, trait mindfulness above meditation-naive population mean) in SBP 
(1.12 mmHg, [-2.68, 4.92]; g = .211, [-.27, .738]) and DBP (-1.2 mmHg, [-3.49, 1.08]; g 
= -.19, [-.54, .162]). Differences in intervention ES in participants with lower and higher 
initial levels of trait mindfulness did not reach significance. 
Aim 3. Are changes in trait mindfulness facets and BP following MBSR training 
correlated, and do these correlations occur across different subgroups (age, gender, race, 
SES) and different initial levels of trait mindfulness? 
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Figure 3. Heatmap of correlations between change (increases) in trait mindfulness and 
change in BP following the intervention. Green indicates that as the trait mindfulness 
facet increased, BP decreased, while red indicates that as the facet increased, so did BP. 
ΔObserving ΔDescribing
ΔActing with 
Awareness
ΔNonjudging ΔNonreactivity ΔDecentering
ΔSBP -0.05 -0.28 0.02 0.05 0.01 -0.08
ΔDBP 0.06 -0.17 0.08 0.22 0.17 0.14
ΔSBP 0.17 -0.10 0.31 0.39 0.34 0.37
ΔDBP 0.57 0.12 0.40 0.61 0.53 0.54
ΔSBP -0.01 -0.44 -0.03 0.03 0.03 -0.09
ΔDBP -0.14 -0.45 -0.02 0.16 0.07 -0.02
ΔSBP -0.62 -0.15 0.34 0.20 0.09 -0.09
ΔDBP 0.13 0.35 0.54 0.39 0.49 0.46
ΔSBP -0.12 -0.30 0.09 0.13 -0.17 -0.23
ΔDBP -0.08 -0.34 -0.11 0.31 -0.09 -0.12
ΔSBP 0.13 -0.39 -0.30 -0.35 0.06 -0.08
ΔDBP 0.06 -0.47 -0.34 -0.16 0.14 0.11
ΔSBP -0.15 -0.34 -0.02 0.27 0.01 -0.17
ΔDBP 0.05 -0.15 0.19 0.38 0.27 0.17
ΔSBP 0.03 -0.19 0.00 -0.20 0.01 0.05
ΔDBP 0.07 -0.23 0.00 0.06 0.08 0.09
ΔSBP -0.01 -0.33 -0.20 0.02 0.04 -0.21
ΔDBP 0.17 -0.58 -0.10 0.36 0.06 0.00
ΔSBP 0.13 -0.26 -0.01 0.04 -0.03 0.20
ΔDBP 0.01 0.01 0.00 0.01 0.11 0.19
ΔSBP 0.03 -0.24 0.31 0.26 0.10 0.04
ΔDBP -0.12 0.18 0.26 0.29 0.37 0.22
ΔSBP -0.01 -0.28 -0.15 -0.04 0.05 -0.11
ΔDBP 0.14 -0.54 -0.10 0.16 0.02 0.07
Higher Initial Trait Mindfulness (n=28)
All MBSR Participants (n=44)
Black Participants (n=11)
White Participants (n=31)
Younger Age Participants (n=11)
Middle Age Participants (n=21)
Older Age Participants (n=13)
Male Participants (n=22)
Female Participants (n=23)
Lower SES Participants (n=23)
Higher SES Participants (n=17)
Lower Initial Trait Mindfulness (n=16)
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To ease interpretation, most participants (82%) had increased trait mindfulness 
following the intervention (x̄ increase across all participants = 14.86 points, or 13%). 
Furthermore, each demographic included in this analysis showed increases in mean trait 
mindfulness. Overall, correlations with change values are likely operating as an increase 
in mindfulness correlated with an increase or decrease in BP. Still, as the group sample 
sizes are particularly small, increasing the possibility of apparent findings being noise, 
these results should be viewed as pilot data to avoid over-interpretation. 
Among all MBSR training group completers (n=44), no correlations between 
change in trait mindfulness facets and change in BP reached clinically relevant ESs. 
Among Black participants (n=11), correlations of change in trait mindfulness facets and 
change in BP were null, as the CIs of the correlation ES contained zero, as shown in 
Appendix E. Among White participants (n=31), correlations reached clinically relevant, 
medium ES in the predicted direction between Describing, SBP (r = -.44, [-.69, -.1]) and 
DBP (r = -.45, [-.69, -.1]), as shown in Figure 3. Correlational differences between 
change in trait mindfulness and change in BP did not reach significance across race, as 
the CIs of each group’s ES overlapped.  
In younger age participants (n=11), correlations reached clinically relevant, large 
ES in the predicted direction in Observing and SBP (r = -.62, [-.89, -.03]), but not DBP, 
as shown in Figure 3. All other correlations between change in trait mindfulness facets 
and change in BP were null, as the CIs of the correlation ESs contained zero, as shown in 
Appendix E. In middle age participants (n=21), all correlations between change in trait 
mindfulness and change in BP were null, as the CIs of the correlation ESs contained zero. 
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Similar null results occurred in older age participants (n=13), as shown in Appendix E. 
Correlational differences between change in trait mindfulness and change in BP did not 
reach significance across age.  
Among both male (n=22) and female (n=23) participants, all correlations between 
change in trait mindfulness and change in BP were null, as the confidence of the 
correlation ESs contained zero. Similar null results occurred across both lower SES 
participants (n=23, household income < $75,000), and higher SES participants (n=17, 
household income > $75,000). Correlational differences between change in trait 
mindfulness and change in BP did not reach significance across SES. Again, among both 
participants with lower initial trait mindfulness (n=16) and participants with higher initial 
trait mindfulness (n=28), all correlations between change in trait mindfulness and change 
in BP were null, as shown in Appendix E. Correlational differences between change in 
trait mindfulness and change in BP did not reach significance across initial level of trait 
mindfulness. 
  
  
 
 
52 
 
Chapter Four 
 
Discussion 
 
The current study aimed to answer three questions about mindfulness, diversity, 
and health. First, at baseline, does higher trait mindfulness relate to lower BP after 
controlling for known covariates of BP, and does this relationship differ as a function of 
demographics (race, age, gender and SES)? No trait mindfulness facets related to BP 
after controlling for covariates of BP. Still, the combination of small but significant 
improvements to R2, alongside the BIC and BF metrics favoring some models accounting 
for demographic interactions over models without said interactions, implies that the 
relationship between some trait mindfulness facets and BP may differ as a function of 
some demographics, potentially driving the appearance of null effects when analyzing the 
sample in its entirety. These significant demographic differences most often occurred 
across race and gender, and in the relationship between Acting with Awareness and 
ambulatory BP, although they appeared across every trait mindfulness facet except 
Decentering, and in each form of BP. The current findings support a null relationship 
between trait mindfulness and BP, that may vary in strength across demographics, 
particularly race and gender. 
Second, does MBSR training lower clinic BP, and does it do so across different 
subgroups and different initial levels of trait mindfulness? Looking at the entire sample, 
MBSR training did not lower clinic BP at clinically relevant levels. However, the current 
findings indicate that MBSR training lowers clinic BP at clinically relevant ES in White 
but not Black people, for whom MBSR training increased BP at clinically relevant ES. 
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While the SBP differences between White and Black participants reached significance, 
no other differences across demographic groups reached significance, likely due to small 
sample size. Regardless, these differences across race may have caused the appearance of 
null effects when the sample was viewed in its entirety.  
Third, are changes in trait mindfulness facets and BP following MBSR training 
correlated, and do these correlations occur across different subgroups and different initial 
levels of trait mindfulness? In the entire sample, change in specific trait mindfulness 
facets did not appear to correlate with change in BP at clinically relevant ES. This is most 
likely due null effects of MBSR training on BP across most demographic groups in the 
current study. However, in White participants, increased Describing correlated with 
decreased BP, and in younger age participants, increased Observing correlated with 
decreased SBP specifically. It is possible that the correlation in younger age participants 
is noise, as BP did not significantly change in younger age participants following MBSR 
training. Other demographic subgroups, namely gender, SES, and the different initial 
levels of trait mindfulness, similarly displayed null results due to the correlation ES CIs 
containing zero. And, differences across demographic subgroups in all the correlations 
between change in trait mindfulness and change in BP did not reach clinical significance, 
likely due to small sample size. 
Overall, these findings tentatively imply that for most demographic groups, we 
cannot assume changes in trait mindfulness drive changes in health resulting from MBSR 
training, or that for some demographic groups, MBSR training will improve health at all. 
The current literature on mindfulness, whether as a state, trait, or training, de-emphasizes 
potential demographic differences in the effects of mindfulness on health and well-being 
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(Chin, Anyanso & Greeson, 2019). While theoretically MBSR training emphasizes skills 
inherent to all people, the assumption that beneficial health-related effects of mindfulness 
are consistent across demographics does not account for significant demographic health 
disparities, including differing rates of disease at a purely biological level, different levels 
of access to healthcare and to other resources necessary for health and well-being, as well 
as disparities in stress, which likely changes in type and intensity in relation to 
demographic subgroup, for example. The current preliminary findings emphasize this 
disparity, illustrating that trait mindfulness might not relate to BP equally across 
demographics, and moreover that MBSR training as an intervention may be effective in 
improving cardiovascular health for one specific racial demographic--people who are 
White—but could conceivably increase BP in other racial demographics, particularly 
people who are Black. In our sample, eight of the eleven Black participants who 
completed MBSR experienced elevated BP, while the remaining three decreased. 
Although these findings are preliminary, they tentatively imply that the relationships 
between mindfulness and other health domains may similarly vary. Future mindfulness 
studies should aim to improve diversity in samples to further explore potential 
demographic differences in the relationship between mindfulness and health, rather than 
assuming beneficial effects generalize across different populations. 
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Appendix E 
 
ΔObserving ΔDescribing
ΔActing with 
Awareness ΔNonjudging ΔNonreactivity ΔDecentering ΔObserving ΔDescribing
ΔActing with 
Awareness ΔNonjudging ΔNonreactivity ΔDecentering
ΔSBP -0.05 -0.28 0.02 0.05 0.01 -0.08 -.34, .251 -.529, .014 -.273, .313 -.249, .336 -.279, .307 -.364, .218
ΔDBP 0.06 -0.17 0.08 0.22 0.17 0.14 -.244, .347 -.443, 134 -.44, .131 -.082, .479 -.129, .442 -.16, .416
ΔSBP 0.17 -0.10 0.31 0.39 0.34 0.37 -.478, .698 -.66, .531 -.354, .768 -.271, .803 -.276, .801 -.297, .792
ΔDBP 0.57 0.12 0.40 0.61 0.53 0.54 -.043, .872 -.518, .67 -.26, .807 .015, .885 -.107, .855 -.082, .862
ΔSBP -0.01 -0.44 -0.03 0.03 0.03 -0.09 -.364, .355 -.688, -.09 -.388, .331 -.33, .389 -.336, 383 -.436, .279
ΔDBP -0.14 -0.45 -0.02 0.16 0.07 -0.02 -.473, .234 -.696, -.106 -.377, .342 -.21, .493 -.295, .421 -.373, .347
ΔSBP -0.62 -0.15 0.34 0.20 0.09 -0.09 -.889, -.034 -.686, .496 -.325, .781 -.451, .716 -.54, .653 -.656, .536
ΔDBP 0.13 0.35 0.54 0.39 0.49 0.46 -.51, .676 -.314, .785 -.082, .862 -.277, .8 -.158, .841 -.191, .831
ΔSBP -0.12 -0.30 0.09 0.13 -0.17 -0.23 -.523, .329 -.645, .155 -.356, .501 -.322, .529 -.56, .282 -.601, .223
ΔDBP -0.08 -0.34 -0.11 0.31 -0.09 -0.12 -.497, .36 -.673, .106 -.52, .334 -.141, .653 -.505, .351 -.523, .33
ΔSBP 0.13 -0.39 -0.30 -0.35 0.06 -0.08 -.456, .633 -.775, .202 -.731, .298 -.755, .249 -.507, .591 -.604, .491
ΔDBP 0.06 -0.47 -0.34 -0.16 0.14 0.11 -.507, .592 -.809, .113 -.75, .258 -.655, .426 -.442, .643 -.466, .625
ΔSBP -0.15 -0.34 -0.02 0.27 0.01 -0.17 -.536, .29 -.667, .093 -.44, .402 -.167, .622 -.416, .426 -.553, .269
ΔDBP 0.05 -0.15 0.19 0.38 0.27 0.17 -.382, .459 -.533, .294 -.255, .563 -.053, .689 -.172, .62 -.274, .549
ΔSBP 0.03 -0.19 0.00 -0.20 0.01 0.05 -.389, .434 -.556, .244 -.41, .413 -.566, .299 -.402, .422 -.366, .456
ΔDBP 0.07 -0.23 0.00 0.06 0.08 0.09 -.347, .472 -.588, .198 -.413, .41 -.457, .364 -.343, 476 -.332, .485
ΔSBP -0.01 -0.33 -0.20 0.02 0.04 -0.21 -.424, .399 -.655, .09 -.563, .234 -.395, .428 -.379, .444 -.571, .222
ΔDBP 0.17 -0.58 -0.10 0.36 0.06 0.00 -.262, .542 -.799, -.217 -.49, .327 -.06, .673 -.362, .46 -.416, .408
ΔSBP 0.13 -0.26 -0.01 0.04 -0.03 0.20 -.371, .576 -.655, .256 -.486, .474 -.466, .513 -.504, .456 -.311 to .62
ΔDBP 0.01 0.01 0.00 0.01 0.11 0.19 -.473, .487 -.47, .49 -.479, .482 -.473, .487 -.388, .563 -.321, .613
ΔSBP 0.03 -0.24 0.31 0.26 0.10 0.04 -.471, .519 -.654, .295 -.216, .7 -.275, .66 -.413, .569 -.463, 526
ΔDBP -0.12 0.18 0.26 0.29 0.37 0.22 -.581, .399 -.342, .622 -.271, .668 -.238, .688 -.151, .732 -.317, .639
ΔSBP -0.01 -0.28 -0.15 -0.04 0.05 -0.11 -.379, .367 -.589, .107 -.497, .233 -.41, .334 -.325, .418 -.46, .278
ΔDBP 0.14 -0.54 -0.10 0.16 0.02 0.07 -.245, .487 -.757, -.204 -.457, .281 -.227, .502 -.352, .393 -.313, .43
Higher Initial Trait Mindfulness (n=28)
All Participants (n=44)
Black Participants (n=11)
White Participants (n=31)
Younger Age Participants (n=11)
Middle Age Participants (n=21)
Older Age Participants (n=13)
Male Participants (n=22)
Female Participants (n=23)
Lower SES Participants (n=23)
Higher SES Participants (n=17)
Lower Initial Trait Mindfulness (n=16)
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